Nothing Special   »   [go: up one dir, main page]

SE0301795D0 - New use I - Google Patents

New use I

Info

Publication number
SE0301795D0
SE0301795D0 SE0301795A SE0301795A SE0301795D0 SE 0301795 D0 SE0301795 D0 SE 0301795D0 SE 0301795 A SE0301795 A SE 0301795A SE 0301795 A SE0301795 A SE 0301795A SE 0301795 D0 SE0301795 D0 SE 0301795D0
Authority
SE
Sweden
Prior art keywords
new use
thiocromans
ibs
enantiomers
salts
Prior art date
Application number
SE0301795A
Other languages
Swedish (sv)
Inventor
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0301795A priority Critical patent/SE0301795D0/en
Publication of SE0301795D0 publication Critical patent/SE0301795D0/en
Priority to TW093116445A priority patent/TW200509904A/en
Priority to ARP040102084A priority patent/AR044717A1/en
Priority to PCT/SE2004/000960 priority patent/WO2004110429A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

The present invention relates to the use of substituted 3-amino chromans or thiocromans as well as enantiomers and salts thereof for the treatment of irritable bowel syndrome (IBS).
SE0301795A 2003-06-19 2003-06-19 New use I SE0301795D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0301795A SE0301795D0 (en) 2003-06-19 2003-06-19 New use I
TW093116445A TW200509904A (en) 2003-06-19 2004-06-08 Use of substituted chromans or thiocromans for the treatment of IBS
ARP040102084A AR044717A1 (en) 2003-06-19 2004-06-16 USE OF SUBSTITUTED CHROMANS OR THIOCHROMANS FOR THE TREATMENT OF IRRITABLE INTESTINE SYNDROME
PCT/SE2004/000960 WO2004110429A1 (en) 2003-06-19 2004-06-16 Use of substituted chromans or thiocromans for the treatment of ibs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301795A SE0301795D0 (en) 2003-06-19 2003-06-19 New use I

Publications (1)

Publication Number Publication Date
SE0301795D0 true SE0301795D0 (en) 2003-06-19

Family

ID=27607360

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301795A SE0301795D0 (en) 2003-06-19 2003-06-19 New use I

Country Status (4)

Country Link
AR (1) AR044717A1 (en)
SE (1) SE0301795D0 (en)
TW (1) TW200509904A (en)
WO (1) WO2004110429A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904361D0 (en) * 1989-12-22 1989-12-22 Astra Ab NEW CHROMAN AND THIOCHROMAN DERIVATIVES
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
DE69218813T2 (en) * 1991-02-08 1997-08-14 Lilly Co Eli Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE510305C2 (en) * 1997-05-30 1999-05-10 Astra Ab Fresh salt

Also Published As

Publication number Publication date
WO2004110429A1 (en) 2004-12-23
AR044717A1 (en) 2005-09-21
TW200509904A (en) 2005-03-16

Similar Documents

Publication Publication Date Title
EA200601553A1 (en) SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES
SE0303180D0 (en) Novel compounds
SE0302232D0 (en) Novel Compounds
DK1682530T3 (en) Pyrrole-substituted indoles as inhibitors of PAI-1
NO20063821L (en) Quinoline derivatives for use as mycobacterial inhibitors
EA200601555A1 (en) Substituted indazole-glucosides
EA200501928A1 (en) Pyrrolodihydroisoquinols as inhibitors of PDE10
EA200601554A1 (en) SUBSTITUTED INDOL-O-GLUCOSIDES
ATE548374T1 (en) 2'-FLUORINE-2'-DESOXYTETRAHYDROURIDINE AS CYTIDE INDEAMINASE INHIBITORS
EA200700188A1 (en) DERIVATIVES OF SUBSTITUTED 2-ALKYLKHINAZOLINON AS PARP INHIBITORS
EA200601686A1 (en) SUBSTITUTED DERIVATIVES OF MORPHOLINE AND THIOMORFOLINE
EA200701396A1 (en) TRIAZOLOPHTHALASINS AS PDE-2 INHIBITORS
MA32544B1 (en) Derivatives of pyridino pyridinone - their preparation and application in treatment
ATE412649T1 (en) SUBSTITUTED HETEROARYLBENZOFURANIC ACIDS
EA201001481A1 (en) Derivatives of tertiary amine as inhibitors of phosphodiesterase-4
DK1789398T3 (en) 2-amino-quinazoline derivatives useful as B-secretase (BACE) inhibitors
NO20081621L (en) Tetrahydroquinolines, synthesis and intermediates
ATE396970T1 (en) 2-(1H-INDOLYLSULFANYL)-BENZYLAMINE DERIVATIVES AS SSRI
EA201000494A1 (en) NEW HYDROXY-8-HETEROARRYFENANTHRIDINES AND THEIR APPLICATION AS PDE4 INHIBITORS
DE60316984D1 (en) BENZOYLSULFONAMIDE AS ANTITUMOR MEDIUM
DE60316128D1 (en) N-sulfonylurea APOPTOSIS PROMOTERS
EA200700400A1 (en) DERIVATIVES N- (1H-INDOLIL) -1H-INDOL-2-CARBOXAMIDES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
ATE419242T1 (en) PYRROLIDINYLUREA DERIVATIVES AS ANGIOGENESIS INHIBITORS
ATE542796T1 (en) N-SULFONYLCARBOXIMIDAMIDE COMPOUNDS AS APOPTOSIS PROMOTERS
AU2003281220A1 (en) N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/ or serotonin reuptake inhibitors